Journal of Virology, September 1998, p. 7075-7083, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Oncology Center,
Received 26 March 1998/Accepted 27 May 1998
Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is indispensable
for viral DNA replication and episome maintenance in latency. Four
promoters, Cp, Wp, Qp, and Fp, are known to drive EBNA1 expression. Here we show that the TATA-less Qp is constitutively active in a
variety of EBV-positive [EBV(+)] tumors and cell lines, irrespective of the activities of other EBNA1 promoters, the type of viral latency,
and the cell type. The transcription of highly regulated promoters such
as the EBV Cp is known to be directly regulated by CpG methylation. To
characterize the role of CpG methylation in the regulation of the
constitutively active Qp, we performed bisulfite genomic sequencing and
functional analyses using a methylation cassette transcriptional
reporter assay. Twenty consecutive CpG sites (16 proximal to the Qp
initiation site and 4 upstream of the adjacent Fp initiation site) were
studied by bisulfite sequencing of DNA extracted from EBV(+) tumors and
cell lines. Eighteen EBV(+) tumors of lymphoid (B, T, and NK cell) or
epithelial origin and five Burkitt's lymphoma cell lines were studied.
The 16 CpG sites proximal to Qp were virtually all unmethylated, but
the 4 CpG sites upstream of the Fp initiation site were variably
methylated. The methylation cassette assay showed that in vitro
methylation of the Qp cassette (
172 to +32) resulted in strong
repression of Qp activity in transient transfection. Thus, Qp is
susceptible to repression by methylation but was found to be
consistently hypomethylated and expressed in all tumors and
tumor-derived cell lines studied.
*
Corresponding author. Mailing address: 418 N. Bond St.,
Johns Hopkins Oncology Center, Baltimore, MD 21231. Phone: (410)
955-5617. Fax: (410) 955-0961. E-mail:
rambind{at}welchlink.welch.jhu.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|